Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study by Ren, Zhenggang, Prof, Xu, Jianming, Prof, Bai, Yuxian, Prof, Xu, Aibing, Prof, Cang, Shundong, Prof, Du, Chengyou, Prof, Li, Qiu, Prof, Lu, Yinying, Prof, Chen, Yajin, Prof, Guo, Yabing, Prof, Chen, Zhendong, Prof, Liu, Baorui, Prof, Jia, Weidong, Prof, Wu, Jian, Prof, Wang, Junye, Prof, Shao, Guoliang, Prof, Zhang, Bixiang, Prof, Shan, Yunfeng, Prof, Meng, Zhiqiang, Prof, Wu, Jianbing, Prof, Gu, Shanzhi, Prof, Yang, Wei, Prof, Liu, Chao, Prof, Shi, Xuetao, Prof, Gao, Zhenyuan, Prof, Yin, Tao, Prof, Cui, Jiuwei, Prof, Huang, Ming, Prof, Xing, Baocai, Prof, Mao, Yilei, Prof, Teng, Gaojun, Prof, Qin, Yanru, Prof, Wang, Jinhai, Prof, Xia, Feng, Prof, Yin, Guowen, Prof, Yang, Yong, MD, Chen, Mingxia, MD, Wang, Yan, MD, Zhou, Hui, MD, Fan, Jia, Prof

Get full text

Real-time artificial intelligence for detection of upper gastrointestinal cancer by endoscopy: a multicentre, case-control, diagnostic study by Luo, Huiyan, Prof, Xu, Guoliang, Prof, Li, Chaofeng, PhD, He, Longjun, MD, Luo, Linna, MD, Wang, Zixian, MD, Jing, Bingzhong, MS, Deng, Yishu, MS, Jin, Ying, MD, Li, Yin, MD, Li, Bin, MS, Tan, Wencheng, MD, He, Caisheng, PhD, Seeruttun, Sharvesh Raj, PhD, Wu, Qiubao, Prof, Huang, Jun, MD, Huang, De-wang, Prof, Chen, Bin, Prof, Lin, Shao-bin, Prof, Chen, Qin-ming, Prof, Yuan, Chu-ming, Prof, Chen, Hai-xin, Prof, Pu, Heng-ying, PhD, Zhou, Feng, PhD, He, Yun, PhD, Xu, Rui-hua, Prof

Get full text